18-04-2019 дата публикации
Номер: US20190111179A1
Автор:
Xiaosong GU,
Fei DING,
Xin TANG,
Yumin YANG,
Bin YU,
Shiying LI,
Songlin ZHOU,
Luzhong ZHANG,
Yaxian WANG,
Yun GU,
Hualin SUN,
GU XIAOSONG,
DING FEI,
TANG XIN,
YANG YUMIN,
YU BIN,
LI SHIYING,
ZHOU SONGLIN,
ZHANG LUZHONG,
WANG YAXIAN,
GU YUN,
SUN HUALIN,
GU, Xiaosong,
DING, Fei,
TANG, Xin,
YANG, Yumin,
YU, Bin,
LI, Shiying,
ZHOU, Songlin,
ZHANG, Luzhong,
WANG, Yaxian,
GU, Yun,
SUN, Hualin
Принадлежит:
Provided is a use of one or more MicroRNA genes selected from miRNAs of Family Let-7, miR-21 or miR-222 in the construction of tissue engineered nerves and in the repair of peripheral nerve defects. An outer and/or internal surface or pores of a tissue engineered nerve graft are coated or adsorbed with polymeric nanomicrospheres carrying a Let-7 family miRNA inhibitor, miR-21, or miR-222, or a mimetic thereof, wherein the polymeric material is composed of biocompatible fibronectin and heparin. The regeneration of peripheral nerves and the construction of tissue engineered nerves are promoted by regulating the expression of MicroRNA genes which can effectively promote the proliferation of primary Schwann cells cultured in vitro and have an anti-apoptotic effect on neuronal cells. In-vivo test proves that bridging of the tissue engineered nerve graft can facilitate the regeneration of peripheral nerves, thus being useful in the treatment of peripheral nerve injury. 1. A method for construction of tissue engineered nerves or repair of peripheral nerve defects , comprising regulating microRNAs (miRNAs) gene expression , wherein the miRNAs are one or more selected from Let-7 family miRNAs , miR-21 , or miR-222.2. The method according to claim 1 , wherein the regulating miRNAs gene expression comprising administering a Let-7 family miRNA inhibitor claim 1 , miR-21 claim 1 , miR-222 claim 1 , or a mimetic thereof to a tissue engineered nerve graft.3. The method according to claim 1 , wherein an outer and/or internal surface or pores of the tissue engineered nerve graft are coated or adsorbed with the Let-7 family miRNA inhibitor claim 1 , miR-21 claim 1 , miR-222 claim 1 , or a mimetic thereof.4. The method according to claim 3 , wherein the Let-7 family miRNA inhibitor claim 3 , miR-21 claim 3 , miR-222 or a mimetic thereof is present on the tissue engineered nerve graft material in an amount of 10 μg/g-10 mg/g.5. The method according to claim 1 , wherein the Let-7 family ...
Подробнее